Investing
The company currently has three prescription digital therapeutics available on the market.
Also: Stanford University spinout Deepcell lands $20 million in funding and Folx raises $4.4 million.
The company projects that sales of its testing kits will triple by the end of 2020.
The company also announced that it is expanding into the Asia Pacific region.
The funding will be used to expand its new prescription therapeutic under the German Digital Healthcare Act.
The company plans to use the new money to expand.
This is Olive's third raise in 2020 alone, and now values the AI company at $1.5 billion.
The company plans to use the funds to propel commercialization efforts and add new technology capabilities.
The funding will enable the health tech startup to grow its platform which automates processes in running clinical research registries.
A Q4 progress report from CB Insights predicts a drop-off in investment between the quarters, for digital health and the broader healthcare startup ecosystem alike.